慢性肾脏病中的高血压:2019核心教程
本文阐述高血压与慢性肾脏病(CKD)相互关联的病理生理机制,涉及肾单位减少、钠潴留、交感神经过度激活、肾素-血管紧张素-醛固酮系统激活及内皮功能障碍。目前CKD患者治疗目标为诊室收缩压<130mmHg,主要管理方法包括限盐、使用血管紧张素转换酶抑制剂或血管紧张素受体阻滞剂及利尿剂。强化血压控制虽未在临床试验中显示延缓CKD进展,但可降低心血管不良结局和死亡风险。
要点
- CKD患者诊室收缩压目标为<130mmHg。
- 管理主要包括限盐、ACEI或ARB及利尿剂治疗。
- 强化降压可降低心血管事件和死亡风险,但未显示延缓CKD进展。
核心结论
- 高血压与CKD互为因果,持续高血压可恶化肾功能,肾功能下降可加重血压控制难度。
- CKD患者诊室收缩压目标为<130mmHg。
- 强化血压控制可降低心血管不良结局和死亡风险,但未显示延缓CKD进展。
研究设计与样本
- 本文为核心教程综述,未报告系统检索范围或样本量。
主要发现
- CKD中高血压的病理生理复杂,涉及肾单位减少、钠潴留和细胞外容量扩张、交感神经过度激活、肾素-血管紧张素-醛固酮系统等激素激活及内皮功能障碍。
- 未控制的高血压可导致显著心血管疾病发病率和死亡率,并加速进展至终末期肾病。
- 临床试验未显示强化血压控制延缓CKD进展,但显示降低心血管不良结局和死亡风险。
关键数值与推荐
- CKD患者诊室收缩压目标为<130mmHg。
- 管理方法包括限盐、起始ACEI或ARB治疗及利尿剂治疗。
临床怎么用
- 对CKD合并高血压患者,应设定诊室收缩压<130mmHg为目标。
- 治疗策略包括限盐、使用ACEI或ARB及利尿剂。
- 强化降压以降低心血管事件和死亡风险,但不应期望延缓CKD进展。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hypertension and chronic kidney disease (CKD) are closely interlinked pathophysiologic states, such that sustained hypertension can lead to worsening kidney function and progressive decline in kidney function can conversely lead to worsening blood pressure (BP) control. The pathophysiology of hypertension in CKD is complex and is a sequela of multiple factors, including reduced nephron mass, increased sodium retention and extracellular volume expansion, sympathetic nervous system overactivity, activation of hormones including the renin-angiotensin-aldosterone system, and endothelial dysfunction. Currently, the treatment target for patients with CKD is a clinic systolic BP < 130mm Hg. The main approaches to the management of hypertension in CKD include dietary salt restriction, initiation of treatment with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, and diuretic therapy. Uncontrolled hypertension can lead to significant cardiovascular morbidity and mortality and accelerate progression to end-stage kidney disease. Although intensive BP control has not been shown in clinical trials to slow the progression of CKD, intensive BP control reduces the risk for adverse cardiovascular outcomes and mortality in the CKD population.
引用
- Ku E, Lee BJ, Wei J, et al. Hypertension in CKD: Core Curriculum 2019. Am J Kidney Dis. 2019. PMID: 30898362. doi:10.1053/j.ajkd.2018.12.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。